Objective: Hypothalamic resistance to the anorexigenic actions of the peripheral adipostat hormone leptin is characteristic of obesity. Here, we use an obese animal model of similar body weight to that of the human to test in vivo whether leptin resistance is due to decreased blood-brain leptin transport or intra-hypothalamic insensitivity, and whether sensitivity to leptin is restored by weight loss. For 40 weeks, adult sheep surgically prepared with intra-cerebroventricular (ICV) cannulae were given a complete natural diet ad libitum ('Obese' group) or in restricted quantities ('Lean' group), and then the dietary amounts were reversed for 16 weeks until mean group body weights converged ('Slimmers' and 'Fatteners', respectively). Results: ICV leptin injection (0.5 mg) at 8-week intervals acutely decreased voluntary food intake by B35% in the 'Obese' group on each occasion and in 'Slimmers' and 'Fatteners' at the end, providing no evidence of intra-hypothalamic insensitivity. The ratio between endogenous leptin concentrations in ventricular cerebrospinal fluid (CSF) and peripheral blood decreased with increasing leptinaemia in 'Obese' sheep, indicating decreased efficiency of blood-brain leptin transport, whereas leptin concentrations remained low and the CSF:blood ratio remained high in 'Lean' sheep. Compared with 'Fatteners' of similar body weight, 'Slimmers' were hypoleptinaemic, but their CSF:blood leptin concentration ratio remained low. Thus, the obesityinduced impairment of leptin blood-brain transport was sustained despite an B15% weight loss. Conclusion: These results support the hypothesis that central resistance to leptin in obesity with associated peripheral hyperleptinaemia is attributable to decreased efficiency of leptin transport into the brain and not to intra-hypothalamic leptin insensitivity. However, leptin transport efficiency is not restored after weight loss by caloric restriction despite the prevailing hypoleptinaemia.
Introduction
Leptin secreted from peripheral adipose tissue acts centrally within the mammalian hypothalamus as an adipostat, reducing appetite and promoting negative energy balance. 1 However, the typically elevated circulating leptin concentrations in obese human beings fail to act in this way, reflecting a state of leptin resistance. 2 To act centrally, leptin from circulating blood must first enter the brain, passing through the blood-cerebrospinal fluid (blood-CSF) barrier at the choroid plexus and/or the blood-brain barrier at the cerebral endothelium, recently reviewed by Ziylan et al. 3 Although leptin resistance may occur at or downstream of its hypothalamic receptor, disorders of leptin blood-brain transport are thought to have a significant function in obesity. 4, 5 Studies in obese human beings report a decreased lumbar CSF to blood leptin concentration ratio, indicative of decreased blood-CSF leptin transfer. 6, 7 Animal studies report a decreased passage rate of leptin into central CSF in fat rats compared with leaner counterparts 8 and in a rat model of dietary-induced central leptin resistance; 9 and greater weight loss is seen in diet-induced obese mice given leptin directly into the brain compared with peripheral injections. 10 Using the larger ovine model, of similar body weight and adiposity to the human, we are able to explore the dynamics of endogenous leptin blood-brain transport longitudinally in vivo from concurrent peripheral blood and intracerebroventricular (ICV) CSF samples while also repeatedly testing intra-hypothalamic leptin sensitivity by direct ICV administration. Thus, the relative importance of the two proposed sites of leptin resistance may be further elucidated during developing obesity within the same animal. Few studies have investigated the restoration of central leptin sensitivity after weight loss in obese subjects, although serum leptin concentrations are reported to decrease disproportionately relative to body fat levels after weight loss by caloric restriction in obese women. 11, 12 This hypoleptinaemia would be exacerbated centrally if leptin resistance persisted at the blood-brain transport level and could contribute to feelings of hunger and the inability to sustain weight loss in the obese slimmer. We have earlier reported striking differences in hypothalamic energy balance regulatory circuits in sheep that had either been fattened or slimmed to the same level of adiposity, whereby orexigenic pathways were strongly up-regulated in the slimmers, 13 consistent with a state of central leptin deficiency. In this study, we continue our investigation of sites of central leptin resistance in obese sheep while they undergo a global calorierestricted weight loss programme to ascertain whether sensitivity is indeed restored. Therefore, this study uses an obese animal model of similar body weight to the human to test in vivo whether leptin resistance is due to decreased blood-brain leptin transport or to intra-hypothalamic insensitivity, and whether sensitivity to leptin is restored by weight loss.
Materials and methods
All experimental procedures involving animals were conducted under the authority of the UK Animals (Scientific Procedures) Act of 1986 and received prior approval from the local Ethical Review Committee.
Animals and dietary treatments
Eighteen adult castrated male sheep (Suffolk Â Greyface crossbreeds, B1 year old) were surgically prepared with two indwelling ICV cannulae into the lateral cerebral ventricle and third ventricle (3 V), as earlier reported.
14 They were housed in individual pens and given a complete diet (comprising 50% chopped hay, 30% rolled barley and 9% soyabean meal, with molasses, minerals, vitamins and trace elements) twice daily at B0800 and 1600 hours, either ad libitum ('Obese' group; minimum 15% food refusal margin) or restricted to B1.1 times the daily amount required to maintain body weight (1.1 Â maintenance; 'Lean' group) for 40 weeks (n ¼ 9 per group). Thereafter for 16 weeks, the daily amount of food was restricted to 0.75 Â maintenance for the 'Obese' animals (now 'Slimmers') and the 'Lean' group was fed ad libitum (now 'Fatteners').
Measurements
Measurements were made of body weight and external adiposity score every 2 weeks. Adiposity score, also known as 'body condition score', was estimated by palpation of the prominence and degree of cover of the spinous and transverse processes of the anterior lumbar vertebrae, scale 0 (emaciated, no body fat) to 5 (extremely obese, 445% body fat), after Russel et al. 15 Voluntary food intake (VFI) of ad libitum food was determined daily at 0800 hours by removing and measuring uneaten food. Mid-morning blood samples (2 h after provision of fresh food) were taken by jugular venepuncture into heparinized vacutainer tubes and CSF was sampled from the lateral cerebral ventricle cannula at B2-week intervals. Samples were immediately chilled on ice; plasma and CSF samples were then stored at 20 1C until analysis.
At 8-week intervals during the 'Obese' phase of the experiment, and again at the end of the 16-week 'Slimming' phase, leptin (recombinant ovine leptin, PLR Ltd, Rehovot, Jerusalem, Israel) was injected ICV (0.5 mg in 0.1 ml 0.9% saline). Injections were given through the 3 V cannula at 0800 hours, immediately before the morning feed, with control injection (0.9% saline) on day 1 and leptin on day 2. For ad libitum-fed sheep, VFI measurements were made at hourly intervals (replacing the uneaten food) for 6 h postinjection and again after 24 h (removing the uneaten food). As 'Lean' sheep consumed their entire meal within 15 min on control days, the weight of any uneaten food left after 15 min on leptin injection days was used to calculate relative eating rate. 'Slimmers' also consumed their regular meals within 15 min, and appetite drive in this group was determined as VFI of an additional test meal of the same diet supplied ad libitum for a 1 h period starting 2 h after ICV injection.
In addition to external adiposity scoring (above), body composition data (total fat, lean and bone mass) were determined by dual energy X-ray absorptiometry (DEXA; Norland XR-26 Mark II, Norland Corporation, Fort Atkinson, WI, USA). DEXA scans were conducted in the morning (0800-1200 hours); food and water were not withheld beforehand, but the provision of fresh food was delayed until after the scan. General inhalation anaesthesia (B2-5% halothane; Halothane BP, Concord Pharmaceuticals Ltd, Essex, UK) was used through a mask to immobilize the animal for the duration of the scan (15-20 min). The coefficient of variation for DEXA measurements of whole body fat, lean and bone mineral content were 3.6, 3.2 and 1.5%, respectively. Scans were obtained at 6, 14 and 22 weeks of the 'Obese' phase of the experiment, and again at the end of the 'Slimming' phase (16 weeks); values are extrapolated for the interim time points when the scanner was unavailable.
All sheep were euthanized at the end of the 'Slimming' phase, after the final ICV leptin injections and DEXA scans, by lethal intravenous dose of pentobarbital sodium (Euthatal; Merial Animal Health Ltd, Harlow, Essex, UK).
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Perirenal and visceral (omental and mesenteric) body fat depots were dissected and weighed immediately post mortem.
Plasma and CSF analyses
Leptin concentrations were determined in duplicate for plasma and CSF by homologous RIA that has earlier been validated in our laboratory. 16 The ovine leptin standard in the RIA was the same leptin preparation as that used for injecting the animals and for raising the antibodies used in the RIA. Intra-and inter-assay coefficient of variations averaged 3 and 9%, respectively, with detection limit 0.05 ng ml
À1
. A subset of plasma samples was analysed for triglycerides and total, lowdensity lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol using an automated analyzer system (KONElab, Labmedics Ltd, Salford Quays, Manchester, UK); variation between duplicates was consistently o5%.
Statistical analysis
The effects of ICV leptin on food intake were examined by ANOVA (Minitab; http://www.minitab.com) using the general linear model with individual sheep, time, treatment (ICV leptin or control) and time Â treatment interaction as specified terms. Additional paired t-tests (Excel, Microsoft Inc., http://www.microsoft.com) were used to compare food intake after leptin vs control ICV injections on each date. The effects of dietary treatments on plasma, CSF and body composition data were examined by ANOVA (Minitab) using the general linear model with individual sheep, time, dietary treatment and time Â treatment interaction as specified terms. Regression analysis was used to test the relationship between DEXA total fat measurements and actual weights of adipose tissue, and correlation, regression and trendline fitting were used to explore relationships between CSF and plasma leptin concentrations (MS Excel). The results are presented as group means ± s.e.m. and differences are deemed significant at Po0.05.
Results
Body weight, adiposity and plasma lipids Mean body weight and external adiposity score in the ad libitum-fed 'Obese' group increased steadily by 77 kg and 2 units, respectively, over the 40 weeks, whereas the 'Lean' group gained just 20 kg with no significant change in adiposity score (Po0.001; Figure 1a Figure 2 Whole body bone, lean and fat mass determined by dual energy X-ray absorptiometry (DEXA) in (a) 'Obese' sheep given ad libitum food for 40 weeks followed by restricted food (now 'Slimmers') for 16 weeks, and (b) 'Lean' sheep given restricted food for 40 weeks followed by ad libitum food (now 'Fatteners') for 16 weeks (n ¼ 9 per group). Dotted lines provide estimated measurements for the interim period when DEXA scanning was unavailable. (c) Weights of perirenal and visceral adipose tissue depots post mortem, and (d) relationship between these combined internal adipose tissue weights and ante mortem DEXA total body fat mass value, at 16 weeks in 'Slimmers' and 'Fatteners'. ***Po0.001, **Po0.01, *Po0.05.
Central leptin resistance in obesity CL Adam and PA Findlay fat and lean mass were greater in 'Obese' than 'Lean' sheep (differences both Po0.001 at 14 and 22 weeks) producing estimated fat:lean ratios at 40 weeks of 0.53 and 0.18, respectively. Actual DEXA measurements were obtained again ante mortem at the end of the 'Slimming' phase, when total body fat content was greater, but lean mass was lower in 'Slimmers' than 'Fatteners' (both Po0.001; Figure 2a and b) despite their similar body weight and external adiposity score. Their final fat:lean ratios were 0.97 ± 0.029 and 0.59±0.051, respectively (Po0.001). Post mortem weights of visceral (Po0.001) and perirenal (Po0.05) adipose tissue were significantly greater in 'Slimmers' than 'Fatteners' (Figure 2c ) and these adipose weights correlated significantly with the ante mortem DEXA whole body fat measurements across both groups, providing a useful validation of the DEXA technique (r ¼ 0.69, Po0.01; Figure 2d) .
At 40 weeks, plasma concentrations of total cholesterol were similar and concentrations of triglycerides (Po0.001) and HDL cholesterol (Po0.05) were lower in 'Obese' sheep compared with 'Lean' sheep, but the LDL/HDL ratio was higher (Po0.05; Table 1 ). At the end of the subsequent 16 weeks, the 'Slimmers' (earlier 'Obese') had similar plasma concentrations of total, HDL and LDL cholesterol, but a lower LDL/HDL ratio and increased plasma triglycerides compared with 'Fatteners' (earlier 'Lean'; both Po0.05; Table 1 ). The LDL/HDL ratio was decreased in 'Slimmers' compared with when they were 'Obese' and increased in 'Fatteners' compared with when they were 'Lean' (both Po0.05; Table 1 ).
Food intake responses to ICV leptin VFI by ad libitum-fed 'Obese' sheep at 8, 16, 24, 32 and 40 weeks was decreased after ICV leptin injection in the immediate 6 h post-injection, and by 35 ± 6.5% over 24 h (Po0.05-o0.001), with no significant change in response over the weeks (Figure 3a and b) . Daily VFI gradually returned to pre-injection levels within 7 days after ICV leptin on each occasion (data not shown). VFI on control injection days increased between 8 and 24 weeks (Po0.001) and remained high until 40 weeks ( Figure 3b) ; these values were representative of the background VFI measurements taken daily throughout (data not shown). At the same time, all 'Lean' sheep consumed their restricted food ration within 15 min after control ICV injection, whereas food refusals remaining at 15 min after ICV leptin indicated a 27±9.0% decrease in eating rate on each occasion (Po0.05; Figure 3c ); all food was consumed within 6 h. After the 'Obese' sheep had subsequently been on caloric restriction for 16 weeks ('Slimmers'), VFI was decreased by ICV leptin during the 1-h period when ad libitum food was provided post-injection (42±7.3%, Po0.01; Figure 3d) . Meanwhile, the 'Fatteners' (originally 'Lean') after 16 weeks with ad libitum food showed significantly decreased VFI over 6 and 24 h (35 ± 9.9%, Po0.01) after ICV leptin (Figure 3e ).
Plasma and CSF leptin concentrations
Plasma leptin concentrations increased continuously throughout the 40 weeks in the 'Obese' group reaching values fivefold greater than those in their 'Lean' counterparts (Po0.001; Figure 4a ). Concurrent CSF leptin concentrations increased in the first 22 weeks to values two-to threefold greater in 'Obese' than 'Lean' sheep, but did not continue to increase thereafter (Po0.001; Figure 4b ) so that the relationship between CSF and plasma leptin concentrations was best described by a logarithmic function (Po0.001; Figure 4c) ; in other words, the CSF:plasma leptin concentration ratio decreased with increasing leptinaemia.
In the second phase of the experiment, plasma and CSF leptin concentrations decreased in 'Slimmers' and increased in 'Fatteners', with final values significantly lower in 'Slimmers' despite their greater adiposity (Po0.001; Figure 4d ). However, the decrease in CSF leptin was disproportionately large in 'Slimmers' (Figure 4e ) so that CSF concentrations did not correlate with those in plasma for this group (Figure 4f) . Meanwhile, the significant CSF:plasma correlation (Po0.01) in 'Fatteners' was similar Central leptin resistance in obesity CL Adam and PA Findlay to that observed in the early stages of the experiment for the 'Obese' group (Figure 4f ).
Discussion
The main findings here in an obese animal model of similar body size to the human were that leptin sensitivity of appetite regulation within the hypothalamus was unaltered, but that the efficiency of blood to brain leptin transfer was decreased, and furthermore, the efficiency of blood-brain leptin transport was not restored after substantial weight loss by global caloric restriction. The ad libitum-fed 'Obese' sheep apparently became leptin resistant as they continued to gain body weight and adipose mass and maintained high VFI despite ever-increasing plasma leptinaemia. However, they showed no evidence of resistance to leptin administered ICV directly into the 3 V at the centre of the hypothalamus, by-passing the blood-brain barrier and blood-CSF barriers. On each occasion during developing and sustained obesity, the 24-h ad libitum food intake decreased by B35% in response to ICV leptin; the anorectic effect started immediately post-injection and only gradually waned over the following days. Similar responses to ICV as opposed to peripherally administered leptin have been reported earlier in sheep 17 and mice, 10 but this is the first report of repeated ICV administration tests in the same individual through developing and sustained obesity. Contemporary 'Lean' sheep showed a significant decrease (B27%) in eating rate immediately after ICV leptin, but with no effect on overall intake as they were given only restricted amounts of food. Leptin concentrations in CSF increased initially along with those in plasma as obesity developed, but, unlike in plasma, the rate of increase in CSF was not sustained. This reflected a decreased proportional transfer of leptin from blood to brain with increased leptinaemia and the reduced CSF:blood leptin concentration ratio in the obese sheep endorses earlier reports of reduced distal CSF:blood leptin in obese human 0  6  5  4  3  2  1  0  6  5  4  3  2  1  0  6  5  4  3  2  1  0  6  5  4  3  2  1  0  6  5  4  3  2  1   8  40  32  24  16  8  40  32  24  16   0  6  5  4  3  2  1 control leptin control leptin Central leptin resistance in obesity CL Adam and PA Findlay beings 6,7 and of decreased blood-CSF leptin transfer in obese rats. 9 Clearly, some leptin was still entering the CSF of obese animals, but the decreased magnitude of the increments within the brain compared with the periphery was insufficient to elicit the anorexic response; by contrast, the acute increase to supraphysiological concentrations within the brain after ICV leptin injection clearly was sufficient to elicit the response. Our data are consistent with leptin entering the brain by a saturable transport system 18 and critically here show this phenomenon in vivo with endogenous leptin. Obesity in our ovine model was characterized by high values for body weight, external adiposity score, DEXA estimates of whole body fat and fat:lean ratio, and for relatively high 'bad' (LDL) cholesterol concentrations in circulating plasma. Global caloric restriction improved the LDL/HDL ratio and induced substantial weight loss. However, a large proportion of the weight loss was lean tissue and 'Slimmers' retained large quantities of adipose tissue. The increased fat:lean ratio in 'Slimmers' was not detected by subjective external adiposity score, which relies heavily on amounts of subcutaneous fat, but was identified by DEXA and verified post mortem by the relatively high weights of visceral and perirenal fat depots. Despite retaining a larger adipose mass, leptinaemia in the slimming animals was disproportionately low compared with the fattening animals so that plasma leptin concentrations did not constitute an accurate adipostat. Leptin secretion seems more sensitive to the direction of change in energy balance rather than to adipose mass per se. 13 Hypoleptinaemia seems to be a feature of slimming, as a greater-than-expected reduction in serum leptin concentrations, as expressed per kilogram of body fat, is also seen after weight loss by caloric restriction in obese women. 11 However, our study here shows additionally that the situation is compounded by a sustained impairment of blood-brain leptin transport, resulting in a more profound hypoleptinaemia within the hypothalamus. Fasting elicits a similar hypoleptinaemic state 19 and it is, therefore, perhaps not surprising that slimmers experience a strong appetite drive that often foils their attempts at weight loss. Obesity and the need for weight loss are relatively recent problems in evolutionary terms, and the leptin signalling system seems more efficient at protecting against starvation than excessive weight gain. The benefits of administering leptin to improve the success of weight loss programmes for the obese have been recognized. 20 Research efforts have also recognized the need to enhance leptin entry into the brain to improve its therapeutic efficacy, 21 for example by intrathecal injection 22 or by modifying the molecule to produce a leptin with improved permeation across the blood-brain barrier, 23 and our study clearly endorses the rationale for this approach. An increased understanding of the causes of the impaired transport would clearly help in this regard. Although hypertriglyceridaemia has been implicated in the decreased transport of leptin across the blood-brain barrier in obese mice, 24 we find no evidence to suggest such an association in sheep. Indeed, plasma triglyceride concentrations were not increased in our obese ovine model, remaining an order of magnitude lower than those reported in the obese mice, possibly because of species and/or dietary differences. Nonetheless, there was a clear association with hyperleptinaemia, consistent with the high concentrations of leptin per se saturating its own transport mechanism, as earlier reported in human 6, 7, 25 and rodent models. 18 Intriguingly, transport efficiency was not restored by a substantial reduction in circulating leptin in our model, indicating that excess leptin did not simply saturate the transport system, but in some way permanently altered its activity. This result contrasts with the recovery of leptin transport function reported in obese mice after weight loss, 26 but may be attributable to differences in methodology as our study measured endogenous native leptin, whereas the latter study measured transport of exogenous radiolabelled leptin. Other studies of leptin blood-brain transfer in obesity have used approaches such as obesity-prone rodent strains or mutants and/or modifications to the composition of the diet (for example reviewed by Ziylan et al. 3 and Banks 4 ) or indeed human lumbar puncture CSF sampling. 6, 7, 25 The present findings provide valuable additional information by studying endogenous leptin transfer from peripheral blood to brain CSF longitudinally in unselected animals given a normal natural balanced diet. The easy access to CSF in large animals as opposed to rodents is clearly advantageous. Therefore, the present results support the hypothesis that central leptin resistance in obesity is attributable to decreased efficiency of blood-brain leptin transport and not to leptin insensitivity within the hypothalamus. A recent comprehensive review of the literature comes to a similar conclusion. 27 In addition, our data show that transport efficiency is not restored after substantial weight loss by global caloric restriction and provide evidence of profound central hypoleptinaemia in obese slimmers, which would be expected to counteract sustained weight loss.
